Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00334438
What this trial is testing

Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
UNC Lineberger Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT02086591
What this trial is testing

A Phase II Study of Doxycycline in Relapsed NHL

Who this might be right for
Adult Diffuse Large B-Cell LymphomaMantle Cell Lymphoma RecurrentLymphoma, Follicular+6 more
University of Rochester 7
Testing effectiveness (Phase 2)Study completedNCT01752426
What this trial is testing

Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00323557
What this trial is testing

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 39
Early research (Phase 1)Study completedNCT00004075
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic
Large-scale testing (Phase 3)Looking for participantsNCT06428019
What this trial is testing

Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT03734198
What this trial is testing

Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia
French Innovative Leukemia Organisation 29
Testing effectiveness (Phase 2)Study completedNCT02968563
What this trial is testing

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 35
Large-scale testing (Phase 3)Looking for participantsNCT06973187
What this trial is testing

Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines 500
Testing effectiveness (Phase 2)Study completedNCT02649387
What this trial is testing

Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
Mayo Clinic 35
Testing effectiveness (Phase 2)Ended earlyNCT04305444
What this trial is testing

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Who this might be right for
Relapsed Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaDiffuse Large B Cell Lymphoma+2 more
Zhejiang DTRM Biopharma 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT05944978
What this trial is testing

GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies

Who this might be right for
Relapsed/Refractory Chronic Lymphocytic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 3
Early research (Phase 1)Study completedNCT00002750
What this trial is testing

Melphalan in Patients With Neoplastic Meningitis

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more
Duke University 6
Testing effectiveness (Phase 2)Study completedNCT00002838
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 13
Early research (Phase 1)WithdrawnNCT03343678
What this trial is testing

This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT01351935
What this trial is testing

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Who this might be right for
B Cell Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia
Celgene 113
Early research (Phase 1)Study completedNCT03019055
What this trial is testing

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellChronic Lymphocytic Leukemia+1 more
Medical College of Wisconsin 26
Early research (Phase 1)Study completedNCT01292135
What this trial is testing

Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 33
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Post-approval studies (Phase 4)Looking for participantsNCT06651970
What this trial is testing

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Who this might be right for
Chronic Lymphocytic LeukaemiaModerate to Severe Cardiac Impairment
AstraZeneca 60
Next Page